Viral Vector Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025
상품코드:1877934
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 12억 7,000만 달러에서 2025년에는 14억 7,000만 달러에 달하고, CAGR 15.8%로 성장이 예상되고 있습니다. 지난 몇 년간의 성장은 유전자 치료 및 세포 치료의 임상 프로그램 증가, 건강 관리 지출 증가, 바이러스 벡터 치료제를 지원하는 조기 규제 승인, 전문 시설에 대한 투자 확대 및 플라스미드 DNA 공급에 대한 의존도 증가로 인한 것으로 예측됩니다.
바이러스 벡터 위탁개발생산(CDMO) 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년까지 26억 1,000만 달러에 달하고, CAGR은 15.4%가 될 전망입니다. 예측기간 동안의 성장요인으로는 일반적인 질환 및 희소질환을 위한 유전자 치료의 상업화 확대, 외부 위탁 생산 능력과 CDMO 투자의 급속한 확대, 규제 조화의 진전, 온디맨드, 개별화, 자가제제 생산에 대한 수요 증가, 만성 질환의 유병률 상승을 들 수 있습니다. 예측기간의 주요 동향으로는 대기업 CDMO와 바이오의약품기업 간의 통합 및 수직통합, 지역별 생산능력 확대, 프로세스 최적화와 규모의 경제에 의한 지속적인 비용 절감에 대한 주력, 플라스미드 DNA 및 비바이러스 플랫폼, 충전 및 마무리 서비스로의 다각화, 디지털 기술과 AI를 활용한 감시 및 품질 관리 도입 등을 들 수 있습니다.
유전자 치료 연구에 대한 투자 확대는 향후 몇 년 동안 바이러스 벡터 위탁개발생산(CDMO) 시장의 성장을 이끌 것으로 예측됩니다. 유전자 치료 연구는 유전성 질환의 교정이나 각종 질환의 치료를 목적으로 인간 세포 내의 유전자를 개조 및 조절하는 수법에 초점을 맞추었습니다. 기존 치료가 어려웠던 유전성 질환에 대해 유전자 치료가 장기적 또는 영구적인 치유를 가져올 가능성으로 이 분야에 대한 투자가 증가하고 있어 헬스케어 이노베이터와 투자자의 강한 관심을 모으고 있습니다. 바이러스 벡터 CDMO는 치료 유전자를 안전하고 효과적으로 전달하기 위해 필수적인 고품질 바이러스 벡터를 생산하기 위한 전문적인 노하우와 고급 생산 시설을 제공함으로써 유전자 치료 조사를 지원합니다. 예를 들어, 2025년 7월에는 영국 생명과학부가 정부로서 최대 8억 달러(6억 파운드)를 투입해 유전체 정보, 진단 정보 및 임상 정보를 국민 차원에서 통합하는 안전하고 AI 대응 의료 데이터 플랫폼을 구축할 방침을 발표했습니다. 이것은 NHS 및 세계 건강 관리 데이터를 연구 및 AI 투자 기지로 전환하는 것을 목표로 합니다. 따라서 유전자 치료 조사에 대한 투자 증가는 바이러스 벡터 CDMO 시장의 성장을 가속하고 있습니다.
바이러스 벡터 CDMO 시장의 주요 기업은 확장성과 효율성을 겸비한 유전자 치료 생산을 지원하기 위해 바이러스 벡터 생산 솔루션의 개발을 추진하고 있습니다. 예를 들어 AAV 생산 솔루션은 유전자 치료를 위해 안전하고 효과적인 아데노 관련 바이러스 벡터를 효율적으로 생산하기 위한 시스템과 기술을 개발하고 있습니다. 2025년 8월 미국에 본사를 둔 CDMO 기업인 ProBio는 뉴저지주 호프웰에 위치한 128,000평방피트의 시설에서 cGMP 준수 AAV 생산 서비스를 시작했습니다. 이 확장은 고품질 바이러스 벡터 생산에 대한 수요 증가에 부응하며 혁신적인 유전자 치료를 지원하는 ProBio의 노력을 입증합니다. 호프웰 시설에서는 GMP 준거 플라스미드 DNA 생산, AAV 벡터 생산, 무균 충전 및 마무리 공정을 포함한 최종 의약품 제제화까지 완전 통합형 서비스를 동일 거점에서 제공합니다. 이 통합 접근법은 조정을 개선하고 공정 간의 인계를 줄이고 의약품 개발 수명주기 전반에 걸친 일정을 가속화합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : 성장률 분석
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 실적 : 규모와 성장, 2019-2024년
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 바이러스 벡터 위탁개발생산(CDMO) :총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : 서비스 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
프로세스 개발
생산
분석시험
충전 및 마무리
기타 서비스 유형
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : 벡터 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
아데노바이러스 벡터
렌티바이러스 벡터
아데노 관련 바이러스 벡터
레트로바이러스 벡터
기타 벡터 유형
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : 워크플로우별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
업스트림 공정 생산
다운스트림 공정 생산
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
유전자 치료
백신
세포요법
기타 용도
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제약 및 생명 공학 기업
학술연구기관
기타 최종 사용자
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : 프로세스 개발 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
업스트림 공정 개발
다운스트림 공정 개발
분석 개발
공정 특성 평가
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : 생산 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
임상 생산
상업 생산
cGMP 생산
세포 뱅크 생산
충전 및 마무리 서비스
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : 분석 시험 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
방출시험
안정성 시험
생물학적 시험
특성 평가 연구
규제 적합성 시험
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : 충전 및 마무리 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
무균 충전
동결건조
최종 포장
콜드체인 관리
라벨링 및 직렬화
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : 기타 서비스 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
규제 지원
공급망 관리
기술이전
임상시험 지원
콜드체인 물류
제7장 지역별/국가별 분석
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
바이러스 벡터 위탁개발생산(CDMO) 시장 : 경쟁 구도
바이러스 벡터 위탁개발생산(CDMO) 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Lonza Group AG : 개요, 제품 및 서비스, 전략 및 재무 분석
WuXi AppTec : 개요, 제품 및 서비스, 전략 및 재무 분석
Samsung Biologics Co. Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
FUJIFILM Biotechnologies
Oxford Biomedica Plc
Hillgene
Takara Bio Inc.
SkyPharma Production SAS
GeneScript ProBio
Obio Technology Corp. Ltd.
VectorBuilder
Charles River Laboratories Pvt. Ltd.
Creative Biogene
Esco Aster Pte. Ltd.
Genesail Biotech Co. Ltd.
CEVEC Pharmaceuticals
Cell and Gene Therapy Catapult
CoJourney
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
바이러스 벡터 위탁개발생산(CDMO) 시장(2029년) : 새로운 기회를 제공하는 국가
바이러스 벡터 위탁개발생산(CDMO) 시장(2029년) : 새로운 기회를 제공하는 부문
바이러스 벡터 위탁개발생산(CDMO) 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
A viral vector contract development and manufacturing organization (CDMO) is a specialized company that focuses on the development and large-scale production of viral vectors used in advanced biological therapies. It provides the necessary technical expertise, infrastructure, and regulatory compliance to support the complete viral vector manufacturing process.
The primary services offered by viral vector CDMOs include process development, manufacturing, analytical testing, fill-finish, and more. Process development in pharmaceutical manufacturing involves designing and optimizing production processes to ensure efficient, scalable, and reproducible outcomes. The different vector types include adenoviral vectors, lentiviral vectors, adeno-associated viral vectors, retroviral vectors, and others, with workflows covering upstream and downstream manufacturing. These services are applied in gene therapy, vaccines, cell therapy, and other areas, and the key end-users include pharmaceutical and biotechnology companies, academic and research institutes, and additional organizations.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The viral vector contract development and manufacturing organization (CDMO) market research report is one of a series of new reports from The Business Research Company that provides viral vector contract development and manufacturing organization (CDMO) market statistics, including viral vector contract development and manufacturing organization (CDMO) industry global market size, regional shares, competitors with a viral vector contract development and manufacturing organization (CDMO) market share, detailed viral vector contract development and manufacturing organization (CDMO) market segments, market trends and opportunities, and any further data you may need to thrive in the viral vector contract development and manufacturing organization (CDMO) industry. This viral vector contract development and manufacturing organization (CDMO) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The viral vector contract development and manufacturing organization (CDMO) market size has grown rapidly in recent years. It will grow from $1.27 billion in 2024 to $1.47 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth during the historic period can be attributed to the increasing number of gene therapy and cell therapy clinical programs, rising healthcare expenditure, early regulatory approvals supporting viral vector therapeutics, growing investments in specialized facilities, and dependence on plasmid DNA supply.
The viral vector contract development and manufacturing organization (CDMO) market size is expected to see rapid growth in the next few years. It will grow to $2.61 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. The growth during the forecast period can be attributed to the commercialization of more gene therapies for both common and rare diseases, rapid expansion of outsourced capacity and CDMO investments, regulatory harmonization, increasing demand for on-demand, personalized, and autologous manufacturing, and the rising prevalence of chronic diseases. Key trends in the forecast period include consolidation and vertical integration among large CDMOs and biopharma companies, regional capacity expansion, ongoing focus on cost reduction through process optimization and economies of scale, diversification into plasmid DNA, non-viral platforms, and fill-finish services, and adoption of digital or AI-enabled monitoring and quality control.
The growing investment in gene therapy research is expected to drive the growth of the viral vector contract development and manufacturing organization (CDMO) market in the coming years. Gene therapy research focuses on methods to modify or regulate genes in human cells to correct genetic disorders or treat various diseases. Investment in this area is increasing due to the potential of gene therapies to provide long-term or permanent cures for previously untreatable genetic conditions, attracting strong interest from healthcare innovators and investors. Viral vector CDMOs support gene therapy research by providing specialized expertise and advanced production facilities to manufacture high-quality viral vectors, which are essential for the safe and effective delivery of therapeutic genes. For example, in July 2025, the UK's Office for Life Sciences reported a government commitment of up to $800 million (£600 million) to develop a secure, AI-compatible health data platform integrating genomic, diagnostic, and clinical information at a population level, aiming to transform NHS and global healthcare data into a hub for research trials and AI investment. Therefore, rising investment in gene therapy research is fueling the growth of the viral vector CDMO market.
Leading companies in the viral vector CDMO market are advancing viral vector manufacturing solutions to support scalable and efficient gene therapy production. AAV manufacturing solutions, for instance, involve systems and techniques developed to efficiently produce safe and effective adeno-associated virus vectors for gene therapy. In August 2025, ProBio, a US-based CDMO, launched cGMP AAV manufacturing services at its 128,000 sq. ft. facility in Hopewell, New Jersey. This expansion meets the growing demand for high-quality viral vector production and demonstrates ProBio's commitment to supporting innovative gene therapies. The Hopewell facility provides fully integrated services including GMP plasmid DNA production, AAV vector manufacturing, and final drug product formulation with aseptic fill-finish, all in one location. This integrated approach improves coordination, reduces process handoffs, and accelerates timelines across the drug development lifecycle.
In May 2023, Siegfried, a Switzerland-based life sciences company, acquired a 95% stake in DINAMIQS for an undisclosed amount. This acquisition allows Siegfried to scale DINAMIQS' capabilities to commercial levels, positioning it as a leading biotech CDMO for cell and gene therapies. The move strengthens Siegfried's presence in the biologics sector and is expected to create significant mid- to long-term growth opportunities in this rapidly evolving market. DINAMIQS provides comprehensive contract development and manufacturing services for viral vectors.
Major players in the viral vector contract development and manufacturing organization (CDMO) market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, WuXi AppTec, Samsung Biologics Co. Ltd., FUJIFILM Biotechnologies, Oxford Biomedica Plc, Hillgene, Takara Bio Inc., SkyPharma Production SAS, GeneScript ProBio, Obio Technology Corp. Ltd., VectorBuilder, Charles River Laboratories Pvt. Ltd., Creative Biogene, Esco Aster Pte. Ltd., Genesail Biotech Co. Ltd., CEVEC Pharmaceuticals, Cell and Gene Therapy Catapult, CoJourney, and Applied Biological Laboratories Inc.
North America was the largest region in the viral vector contract development and manufacturing organization (CDMO) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in viral vector contract development and manufacturing organization (CDMO) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the viral vector contract development and manufacturing organization (CDMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The viral vector contract development and manufacturing organization (CDMO) market consists of revenues earned by entities by providing services such as cell line development, preclinical material production, quality control testing, and supply chain management. The market value includes the value of related goods sold by the service provider or included within the service offering. The viral vector contract development and manufacturing organization (CDMO) market also includes sales of helper plasmids, packaging cell lines, producer cell banks, and purified viral vector components. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Viral Vector Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on viral vector contract development and manufacturing organization (cdmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for viral vector contract development and manufacturing organization (cdmo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral vector contract development and manufacturing organization (cdmo) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Service Type: Process Development; Manufacturing; Analytical Testing; Fill-Finish; Other Service Types
2) By Vector Type: Adenoviral Vectors; Lentiviral Vectors; Adeno-Associated Viral Vectors; Retroviral Vectors; Other Vector Types
3) By Workflow: Upstream Manufacturing; Downstream Manufacturing
4) By Application: Gene Therapy; Vaccines; Cell Therapy; Other Applications
5) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Process Development: Upstream Process Development; Downstream Process Development; Analytical Development; Process Characterization
2) By Manufacturing: Clinical Manufacturing; Commercial Manufacturing; cGMP Manufacturing; Cell Bank Production; Fill-Finish Services
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Characteristics
3. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies
4. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Growth Analysis And Strategic Analysis Framework
5.1. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Growth Rate Analysis
5.4. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM)
6. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Segmentation
6.1. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Process Development
Manufacturing
Analytical Testing
Fill-Finish
Other Service Types
6.2. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adenoviral Vectors
Lentiviral Vectors
Adeno-Associated Viral Vectors
Retroviral Vectors
Other Vector Types
6.3. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Upstream Manufacturing
Downstream Manufacturing
6.4. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gene Therapy
Vaccines
Cell Therapy
Other Applications
6.5. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Academic And Research Institutes
Other End-Users
6.6. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Process Development, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Upstream Process Development
Downstream Process Development
Analytical Development
Process Characterization
6.7. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Manufacturing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Manufacturing
Commercial Manufacturing
cGMP Manufacturing
Cell Bank Production
Fill-Finish Services
6.8. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Analytical Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Release Testing
Stability Testing
Bioassays
Characterization Studies
Regulatory Compliance Testing
6.9. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Aseptic Filling
Lyophilization
Final Packaging
Cold Chain Management
Labeling and Serialization
6.10. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Other Service Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Regulatory Support
Supply Chain Management
Technology Transfer
Clinical Trial Support
Cold Chain Logistics
7. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis
7.1. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
8.1. Asia-Pacific Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
9.1. China Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
9.2. China Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
10.1. India Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
11.1. Japan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
11.2. Japan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
12.1. Australia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
13.1. Indonesia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
14.1. South Korea Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
14.2. South Korea Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
15.1. Western Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
15.2. Western Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
16.1. UK Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
17.1. Germany Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
18.1. France Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
19.1. Italy Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
20.1. Spain Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
21.1. Eastern Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
21.2. Eastern Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
22.1. Russia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
23.1. North America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
23.2. North America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
24.1. USA Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
24.2. USA Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
25.1. Canada Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
25.2. Canada Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
26.1. South America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
26.2. South America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
27.1. Brazil Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
28.1. Middle East Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
28.2. Middle East Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
29.1. Africa Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
29.2. Africa Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles
30.1. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape
30.2. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. WuXi AppTec Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Samsung Biologics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies
31.1. FUJIFILM Biotechnologies
31.2. Oxford Biomedica Plc
31.3. Hillgene
31.4. Takara Bio Inc.
31.5. SkyPharma Production SAS
31.6. GeneScript ProBio
31.7. Obio Technology Corp. Ltd.
31.8. VectorBuilder
31.9. Charles River Laboratories Pvt. Ltd.
31.10. Creative Biogene
31.11. Esco Aster Pte. Ltd.
31.12. Genesail Biotech Co. Ltd.
31.13. CEVEC Pharmaceuticals
31.14. Cell and Gene Therapy Catapult
31.15. CoJourney
32. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
34. Recent Developments In The Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
35. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies
35.1 Viral Vector Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Countries Offering Most New Opportunities
35.2 Viral Vector Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Segments Offering Most New Opportunities
35.3 Viral Vector Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Growth Strategies
